Vaccination and Immunotherapy against COVID-19

 Sunday, May 8, 2022     3:45 PM – 5:45 PM ET     Oregon Ballroom 204

Vaccination and Immunotherapy against COVID-19

Chairs

• Donna L. Farber, Columbia Univ. Med. Ctr.
• James J. Kobie, Univ. of Alabama at Birmingham

Speakers

• Ebony Nicole Gary, Wistar Inst., Peripheral co-immunization with CCL27 drives robust mucosal responses to SARS-CoV-2 synDNA antigens and provides heterologous protection against Delta variant challenge
• Vanessa S. Moraes, Univ. of Georgia, Polyfunctionality of T cell immunity in pre-immune and naïve individuals after COVID-19 mRNA vaccination
• Elizabeth A. Thompson, Johns Hopkins Univ. Sch. of Med., Alternative lineage B cells utilizing fatty acid oxidation predict response to third dose COVID vaccination in solid organ transplant recipients
• James Kobie, Univ. of Alabama at Birmingham, Pan-coronavirus neutralizing S2 human monoclonal antibodies and utility of direct respiratory administration as combination therapy with S1 antibodies against SARS-CoV-2
• Timothy A. Bates, Oregon Hlth. and Sci. Univ., Hybrid immunity and vaccine breakthrough lead to robust humoral response and antibodies that effectively neutralize SARS-CoV-2 variants
• Eric S. Geanes, Children’s Mercy Kansas City, Differences between autoantibodies induced by SARS-CoV-2 infection and Pfizer-BioNTech SARS-CoV-2 vaccination
• Julia Davis-Porada, Columbia Univ. Med. Ctr., Persistence of immune memory to SARS-CoV-2 vaccine in lymphoid tissue
• John D. Mountz, Univ. of Alabama at Birmingham, IL-4R blockade prevents a long term memory B cell response to COVID-19 vaccination